— Know what they know.
Not Investment Advice

PRRUF OTC

Immutep Ltd
1W: -25.0% 1M: -25.0% 3M: -40.0% YTD: -90.6% 1Y: -84.2% 3Y: -85.0% 5Y: -88.5%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $44.2M mcap · 1.43B float · 0.0000% daily turnover · Short 74% of daily vol

Income Trends

Revenue
$15M +188.2% ▲
5Y CAGR: +30.4%
Gross Profit
$12M +121.4% ▲
Operating Income
-$84M +33.7% ▲
Net Income
-$79M -28.9% ▼
EPS (Diluted)
$-0.05 -27.5% ▼
EBITDA
-$81M -29.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$170K$4M$4M$5M$15M
YoY Growth-95.6%+1957.7%+9.6%+31.3%+188.2%
Cost of Revenue$31M$2M$42M$61M$2M
Gross Profit-$27M$1M-$38M-$56M$12M
Gross Margin-15629.1%41.2%-981.4%-1117.6%83.0%
R&D Expenses$25M$29M$42M$61M$77M
SG&A Expenses$7M$14M$9M$9M$19M
Operating Expenses$33M$45M$50M$70M$96M
Operating Income-$34M-$78M-$88M-$126M-$84M
Operating Margin-19920.0%-2216.0%-2293.3%-2506.5%-576.2%
Interest Expense$92K$20K$31K$0$68K
Income Before Tax-$32M-$40M-$43M-$61M-$79M
Tax Expense$34$0$0$0$0
Net Income-$32M-$40M-$43M-$61M-$79M
Net Margin-18906.5%-1138.0%-1111.9%-1218.0%-544.8%
EPS (Diluted)$-0.04$-0.04$-0.04$-0.04$-0.05
EBITDA-$32M-$40M-$45M-$63M-$81M
Shares Outstanding862M901M1.20B1.46B1.47B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms